|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis显示文摘The congenital dyserythropoietic anemias comprise agroup of rare hereditary disorders of erythropoiesis,characterized by ineffective erythropoiesis as thepredominant mechanism of anemia and by characteristicmorphological aberrations of the majority of erythroblastsin the bone marrow.Congenital dyserythropoieticanemia type II is the most frequent type.All types ofcongenital dyserythropoietic anemias distinctly share ahigh incidence of iron loading.Iron accumulation occurseven in untransfused patients and can result in heartfailure and liver cirrhosis.We have reported about apatient who presented with liver cirrhosis and intractableascites caused by congenital dyserythropoietic anemiatype Ⅱ.Her clinical course was further complicatedby the development of autoimmune hemolyticanemia.Splenectomy was eventually performed whichachieved complete resolution of ascites,increase ofhemoglobin concentration and abrogation of transfusionrequirements. | Themistoklis Vassiliadis Vassilia Garipidou Vassilios Perifanis Konstantinos Tziomalos OIga Giouleme Kalliopi Patsiaoura Michalis Avramidis Nikolaos Nikolaidis Sofia Vakalopoulou Ioannis Tsitouridis Antonios Antoniadis Panagiotis Semertzidis Anna Kioumi Evangelos Premetis Nikolaos Eugenidis | 2006 | World Journal of Gastroenterology2006，12，5： | 47 |
| 2 | Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat显示文摘AIM: To present the characteristics and the course of a series of anti- hepatitis B virus core antibody (HBc) antibody positive patients, who experienced hepatitis B virus (HBV) reactivation after immunosuppression. METHODS: We retrospectively evaluated in our tertiary centers the medical records of hepatitis B virus surface antigen (HBsAg) negative patients who suffered from HBV reactivation after chemotherapy or immunosuppression during a 3-year period (2009-2011). Accordingly, the clinical, laboratory and virological characteristics of 10 anti-HBc (+) anti-HBs (-)/HBsAg (-) and 4 anti-HBc (+)/antiHBs (+)/HBsAg (-) patients, who developed HBV reactivation after the initiation of chemotherapy or immunosuppressive treatment were analyzed. Quantitative determination of HBV DNA during reactivation was performed in all cases by a quantitative real time polymerase chain reaction kit (COBAS Taqman HBV Test; cut-off of detection: 6 IU/mL). RESULTS: Twelve out of 14 patients were males; median age 74.5 years. In 71.4% of them the primary diagnosis was hematologic malignancy; 78.6% had received rituximab (R) as part of the immunosuppressive regimen. The median time from last chemotherapy schedule till HBV reactivation for 10 out of 11 patients who received R was 3 (range 2-17) mo. Three patients (21.4%) deteriorated, manifesting ascites and hepatic encephalopathy and 2 (14.3%) of them died due to liver failure. CONCLUSION: HBsAg-negative anti-HBc antibody positive patients can develop HBV reactivation even 2 years after stopping immunosuppression, whereas prompt antiviral treatment on diagnosis of reactivation can be lifesaving. | Kalliopi Zachou Alexandros Sarantopoulos Nikolaos K Gatselis Themistoklis Vassiliadis Stella Gabeta Aggelos Stefos Asterios Saitis Panagiota Boura George N Dalekos | 2013 | World Journal of Hepatology2013，5，7： | 6 |
| 3 | Insect-plant-pathogen interactions as shaped by future climate effects on biology, distribution, and implications for agriculture显示文摘 | Piotr Trebicki Beatriz Dader Simone Vassiliadis Alberto Fereres | 2017 | Insect Science2017，24，6： | 6 |
| 4 | ARKTOS: towards the modeling, design, control and execution of ETL processes显示文摘 | Panos Vassiliadis Zografoula Vagena Spiros Skiadopoulos Nikos Karayannidis Timos Sellis | 2001 | Infornation Systems2001，26，8： | 2 |
| 5 | In vitro reconstitution of the first steps of anatoxin-a biosynthesis in Oscillatoria PCC 6506: from free L-proline to acyl carrier protein bound dehydroproline显示文摘 | Mejean A Mann S Vassiliadis G | 2010 | Biochemistry2010，49，1： | 1 |
| 6 | Endogenous subclinical hypercotisolism:diagnostic uncertainties and clinical implications显示文摘 | Vassiliadi D Thalassinos N | 2006 | J Endo Invest2006，29，： | 1 |
| 7 | The application of the combined eorticotmpin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopie adrenoeortieotmpin syndrome显示文摘 | Tsagarakis S Vassiliadi D Kaskarelis IS | 2007 | J Clin Endocfinol Metab2007，92，： | 1 |
| 8 | A Survey on Logical Models for OLAP Databases 显示文摘 | P Vassiliadis T Seilis | 2002 | Communications of the ACM2002，28，4： | 1 |
| 9 | The influence of the smear layer on dentinal tubule penetration depth by three different root canal sealers: an in vitro study显示文摘 | Kokkas AB Boutsioukis A Vassiliadis LP | 2004 | J Endod2004，30，： | 1 |
| 10 | Sensitivity of Conceptual Rainfall-runoff Algorithms to Errors in Input Data-Case of the GR2M Model显示文摘 | Paturel J E Servat E Vassiliadis A | 1995 | Journal of Hydrology1995，168，14： | 1 |
| 11 | The MOLEN polymorphic processor显示文摘 | Vassiliadis S Wong S Gaydadjiev G | 2004 | IEEE Transactions on Computers2004，53，11： | 1 |
| 12 | Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection: two cases显示文摘 | S. Aslanidis T. Vassiliadis A. Pyrpasopoulou I. Douloumpakas C. Zamboulis | 2007 | Clinical Rheumatology2007，，2： | 1 |
| 13 | Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels 显示文摘 | Vassiliadi DA Tzanela M Kntanidou A | 2012 | J Crit Care2012，27，4： | 1 |
| 14 | Constitutive or induced elevated levels ofL-carnitine correlate with the cytokine and cellular profile of endometriosis显示文摘 | Dionyssopoulou E Vassiliadis S Evangeliou A | | 0，，02： | 1 |
| 15 | Towards the Modeling,Design, Control and Execution of ETL Processes显示文摘 | Vassiliadis P Vagena Z Skiadopoulos S | 2001 | Information Systems2001，26，8： | 1 |
| 16 | Endogenous Subclinical hypercortisolism:diagnostic uncertainties and clinical implications显示文摘 | Tsagarakis S Vassiliadi D Thalassinos N | 2006 | J Endocrinol Invest2006，29，5： | 1 |
| 17 | Localization and expression of CCR3 and CCR5 by interleukin-1 beta in the RIN-5AH insulin-producing model system: a protective mechanism involving down-regulation of chemokine receptors 显示文摘 | VASSILIADIS S BALABANIDOU V PAPADOPOULOS GK Athanassakis I | 2002 | JOP2002，3，3： | 1 |
| 18 | Sudden death due to cardiac myxomas显示文摘 | Vassiliadis N Vassiliadis K Karravelas G | 1997 | Med Sei Law1997，37，1： | 1 |
| 19 | ARKTOS: Towards the Modeling, Design, Control and Execution of ETL Processes显示文摘 | VASSILIADIS P VAGENA Z SKIADOPOULOS S | 2001 | Information Systems2001，26，8： | 1 |
| 20 | Evolution of low-and intermediate-mass stars to the end of the asymptotic giant branch with mass loss 显示文摘 | VASSILIADIS E WOOD P R | 1993 | ApJ1993，413，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员